RUA — Rua Bioscience Share Price
0.000.00%
Last trade - 00:00- NZ$9.67m
- NZ$9.64m
- NZ$0.09m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.54 | ||
| Price to Tang. Book | 2.37 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 12.68 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -73.46% | ||
| Return on Equity | -59.31% | ||
| Operating Margin | -610.71% | ||
Financial Summary
| Year End 30th Jun | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | NZ$m | n/a | n/a | 0.02 | 0.36 | 0.09 | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Rua Bioscience Limited is a New Zealand-based medicinal cannabis company. The Company is principally engaged in the research and development, sale, and marketing of pharmaceutical products in Germany, Australia, and New Zealand. It focuses on areas such as Plant Discovery and Breeding, as well as the International Sales and Marketing of medicinal cannabis. The Company supplies Good Manufacturing Practice (GMP)-certified medicines to expanding markets, supported by international supply agreements in Europe and a partnership in Australia for GMP-certified products. The Company has also invested in its subsidiary, Rua Bioscience Australia Pty Ltd.
Directors
- Trevor Burt CHM (63)
- Rob Mitchell CEO
- Hamish White CFO
- Manu Caddie OTH
- Andrea Grant OTH
- Panapa Ehau DRC
- Brett Gamble DRC
- Martin Smith DRC
- Anna Stove IND
- Last Annual
- June 30th, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- October 26th, 2017
- Public Since
- October 22nd, 2020
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- New Zealand Stock Exchange
- Shares in Issue
- 214,848,012
- Address
- 1 Commerce Place, Awapuni, GISBORNE, 4071
- Web
- https://www.ruabio.com
- Phone
- +64 63906938
- Auditors
- PricewaterhouseCoopers Chartered Accountants
Upcoming Events for RUA
Rua Bioscience Ltd Annual Shareholders Meeting
Similar to RUA
AFT Pharmaceuticals
New Zealand Stock Exchange
BLIS Technologies
New Zealand Stock Exchange
EBOS
New Zealand Stock Exchange
FAQ
What is the Rua Bioscience share price?
As of Today at 05:00 UTC, shares in Rua Bioscience are trading at NZ$0.05. This share price information is delayed by 15 minutes.
How has the Rua Bioscience share price performed this year?
Shares in Rua Bioscience last closed at NZ$0.05 and the price had moved by +2.27% over the past 365 days. In terms of relative price strength the Rua Bioscience share price has underperformed the ASX All Ordinaries Index by -4.3% over the past year.
What are the analyst and broker recommendations for Rua Bioscience?
There is no consensus recommendation for this security.
Find out moreWhat is the Rua Bioscience dividend yield?
Rua Bioscience does not currently pay a dividend.
Does Rua Bioscience pay a dividend?
Rua Bioscience does not currently pay a dividend.
When does Rua Bioscience next pay dividends?
Rua Bioscience does not currently pay a dividend.
How do I buy Rua Bioscience shares?
To buy shares in Rua Bioscience you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Rua Bioscience?
As of the previous close price of NZ$0.05, shares in Rua Bioscience had a market capitalisation of NZ$9.67m.
Where are Rua Bioscience shares listed?
Here are the trading details for Rua Bioscience:
- Country of listing: New Zealand
- Exchange: NZC
- Ticker Symbol: RUA
What kind of share is Rua Bioscience?
Based on an overall assessment of its quality, value and momentum Rua Bioscience is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Rua Bioscience share price forecast for 2025?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the Rua Bioscience share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Rua Bioscience. Over the past six months, its share price has outperformed the ASX All Ordinaries Index by +50.15%.
As of the last closing price of NZ$0.05, shares in Rua Bioscience were trading +46.89% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Rua Bioscience PE Ratio?
The Rua Bioscience PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at NZ$0.05.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Rua Bioscience?
Rua Bioscience's management team is headed by:
- Trevor Burt - CHM
- Rob Mitchell - CEO
- Hamish White - CFO
- Manu Caddie - OTH
- Andrea Grant - OTH
- Panapa Ehau - DRC
- Brett Gamble - DRC
- Martin Smith - DRC
- Anna Stove - IND